References
- McCoy WF, Bryers JD, Robbins J, et al. Observations of fouling biofilm formation. Can J Microbiol. 1981;27(9):910–917. doi: 10.1139/m81-143
- Otto M, Fischetti VA, Novick RP, et al. Staphylococcal Biofilms. Microbiol Spectr. 2018;6(4). doi: 10.1128/microbiolspec.GPP3-0023-2018
- Hall CW, Mah TF. Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. FEMS Microbiol Rev. 2017;41(3):276–301. doi: 10.1093/femsre/fux010
- Pinto RM, Lopes-de-Campos D, Martins MCL, et al. Impact of nanosystems in staphylococcus aureus biofilms treatment. FEMS Microbiol Rev. 2019;43(6):622–641. doi: 10.1093/femsre/fuz021
- Tarakji KG, Mittal S, Kennergren C, et al. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection. N Engl J Med. 2019;380(20):1895–1905. doi: 10.1056/NEJMoa1901111
- Brady RA, O’May GA, Leid JG, et al. Resolution of staphylococcus aureus biofilm infection using vaccination and antibiotic treatment. Infect Immun. 2011;79(4):1797–1803. doi: 10.1128/IAI.00451-10
- Silva E, Teixeira JA, Pereira MO, et al. Evolving biofilm inhibition and eradication in clinical settings through plant-based antibiofilm agents. Phytomedicine. 2023;119:154973. doi: 10.1016/j.phymed.2023.154973
- Pletzer D, Coleman SR, Hancock RE. Anti-biofilm peptides as a new weapon in antimicrobial warfare. Curr Opin Microbiol. 2016;33:35–40. doi: 10.1016/j.mib.2016.05.016
- Zapotoczna M, Forde E, Hogan S, et al. Eradication of Staphylococcus aureus Biofilm Infections Using Synthetic Antimicrobial Peptides. J Infect Dis. 2017;215(6):975–983. doi: 10.1093/infdis/jix062
- Park SC, Lee MY, Kim JY, et al. Anti-biofilm effects of synthetic antimicrobial peptides against drug-resistant Pseudomonas aeruginosa and staphylococcus aureus planktonic cells and biofilm. Molecules. 2019;24(24):4560. doi: 10.3390/molecules24244560
- Joo HS, Otto M. Mechanisms of resistance to antimicrobial peptides in staphylococci. Biochim Biophys Acta. 2015;1848(11 Pt B):3055–3061. doi: 10.1016/j.bbamem.2015.02.009
- Suh GA, Lodise TP, Tamma PD, et al. Considerations for the use of phage therapy in clinical practice. Antimicrob Agents Chemother. 2022;66(3):e0207121. doi: 10.1128/aac.02071-21
- Danis-Wlodarczyk KM, Wozniak DJ, Abedon ST. Treating bacterial infections with bacteriophage-based enzybiotics: In vitro, in vivo and clinical application. Antibiotics. 2021;10(12):1497. doi: 10.3390/antibiotics10121497
- Lacey KA, Serpas L, Makita S, et al. Secreted mammalian DNases protect against systemic bacterial infection by digesting biofilms. J Exp Med. 2023;220(6). doi: 10.1084/jem.20221086
- Otto M. Critical assessment of the prospects of quorum-quenching therapy for staphylococcus aureus infection. Int J Mol Sci. 2023;24(4):4025. doi: 10.3390/ijms24044025